Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-23

FDA Approved: DESOXIMETASONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for desoximetasone from Padagis Israel Pharmaceuticals Ltd, finalizing an update to the approved ANDA. Desoximetasone is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desoximetasone (Desoximetasone)

Snippet

SUPPL AP for DESOXIMETASONE (DESOXIMETASONE)